In the 12 months after starting tezepelumab, patients with severe asthma had fewer exacerbations, a lower cumulative oral ...

Early-life viral infection programs immune cells to hijack allergy-associated maternal antibodies, driving allergy risk later ...

About 20 million people in the U.S.—including four million children—have food allergies. Now, there's a new way to reduce their risk of severe allergic reactions. A study published in the New England ...

Scientists found that RSV infection early in life can set the stage for childhood asthma, particularly in kids already genetically prone to allergies. The virus appears to skew the developing immune ...

A new study finds that thunderstorms can trigger sharp increases in asthma-related emergency department (ED) visits, underscoring the importance of storm preparedness for people with asthma.

Early-life RSV infection and parental allergy interact to substantially increase childhood asthma risk, supported by ...

Monthly injection with tezepelumab helped 90% of patients with severe asthma reduce intake of daily steroid tablets. The ...

With a little planning, people can enjoy the celebrations without spending them sniffing, itchy or reaching for tissues. because of allergy and asthma triggers that can sour your holiday season.

According to a new published study pulmonary rehabilitation (PR) significantly lowered Fractional exhaled nitric oxide (FeNO) ...

GSK plc announced the marketing authorisation of Exdensur (depemokimab) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Exdensur is now approved in two indications: ...